Bolland and colleagues previously conducted a 2-year controlled, blind study in postmenopausal women who received hydrochlorothiazide 50 mg daily or placebo. There were significant, sustained ...

Design: This was a phase IV, multicentre, single-blind ... ≤95mm Hg were randomised to receive amlodipine 5 mg/day or hydrochlorothiazide 50 mg/day for 8 weeks (phase II).